Skip to content

Released Mar 1, 2017, after the close

10-K filed Mar 2, 2017, 61 days after period end · 0001144204-17-012234

Q4 2016 · 10-K
Revenue—
Net Income-$11.55MN/M vs Q4 2015N/M vs Q3 2016
EPS Diluted-$0.67N/M vs Q4 2015N/M vs Q3 2016
Operating Incomederived-$11,867,793N/M
Operating Cash Flowderived-$11,039,580N/M
Free Cash Flowderived-$11,151,486N/M

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2016Q4 2015Q4 2014derived from reported figuresQ4 2013derived from reported figures
Net Income-$11.55M-$7.75M-$6.23M-$6.05M
EPS Diluted-$0.67-$0.45——

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR